Melissa R. Junttila

Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy

Claudia X. Dominguez, Sören Müller, Shilpa Keerthivasan et al. · Cancer Discovery · 2019 · 806 citations

CIP2A Inhibits PP2A in Human Malignancies

Melissa R. Junttila, Pietri Puustinen, Minna Niemelä et al. · Cell · 2007 · 675 citations · Full text

Tumor Biology, Cip2a Inhibits Pp2a, Medicine +5

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

Daniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison et al. · Journal of Clinical Oncology · 2015 · 524 citations

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors

Diego O. Croci, Juan P. Cerliani, Tomás Dalotto‐Moreno et al. · Cell · 2014 · 487 citations · Full text

Angiogenesis, Vascular Biology, Anti-vegf Refractory Tumors +5

Distinct Thresholds Govern Myc's Biological Output In Vivo

Daniel J. Murphy, Melissa R. Junttila, Laurent Pouyet et al. · Cancer Cell · 2008 · 454 citations · Full text

Signal Transduction, In Vivo System, Physiology +7